Thursday, November 10, 2005 11:32:19 AM
CompuMed, Inc. Announces Common Stock Purchase Rights Dividend
Thursday November 3, 9:15 am ET
LOS ANGELES, Nov. 3 /PRNewswire-FirstCall/ -- CompuMed, Inc. (OTC Bulletin Board: CMPD - News) -- a medical informatics company serving the healthcare community with diagnostic software solutions -- today announced that its Board of Directors has declared a dividend distribution of one common stock purchase right on each outstanding share of its common stock.
The action taken by the Board of Directors is designed to protect the long-term value of shareholders' and employees' investment in CompuMed, Inc., and to assure that they receive fair and equal treatment in the event of any proposed takeover effort, including a partial tender offer, squeeze-out, open market accumulation or other coercive tactic to gain control of CompuMed, Inc. without paying all shareholders a fair control premium. The declaration was approved and implemented by management as a routine action. The Company is not aware of any current attempt to acquire control of CompuMed, Inc.
Until the rights become exercisable, they will trade automatically with the common stock of CompuMed, Inc. Separate rights certificates will not be issued. The rights will be exercisable only if a person or group (1) acquires 15% or more of CompuMed, Inc.'s common stock, whether through open market or private purchases or consummation of a tender or exchange offer, or (2) announces an offer the consummation of which would result in such person or group owning 15% or more of CompuMed, Inc.'s common stock. When the rights first become exercisable, each right will entitle the holder to purchase one share of common stock for $0.40, subject to adjustment.
The rights are intended to enable all shareholders to realize the long-term value of their investment in CompuMed, Inc. They will not prevent a takeover, but should encourage anyone seeking to acquire CompuMed, Inc. to negotiate with the Board prior to attempting a takeover. The Board may redeem the rights for $0.001 per right prior to the acquisition of 15% or more of our common stock by a single acquirer or group.
About CompuMed:
Founded in 1973, CompuMed, Inc. (OTC Bulletin Board: CMPD - News) is a leading provider of computer-aided telemedicine and diagnostics technology. The Company's core products are the OsteoGram and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. CompuMed is headquartered in Los Angeles. Visit CompuMed at http://www.compumed.net or call (310) 258-5000.
This news release contains forward-looking statements. Forward-looking statements include statements concerning CompuMed's plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission. All such forward-looking statements are expressly qualified by these cautionary statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.
http://biz.yahoo.com/prnews/051103/nyth099.html?.v=27
Recent VTSI News
- VirTra Simulators Approved for DoD-Funded Research Projects • GlobeNewswire Inc. • 06/13/2024 12:30:00 PM
- VirTra Set to Join Russell 3000® Index • GlobeNewswire Inc. • 06/04/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:05:22 PM
- VirTra Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- VirTra Sets First Quarter 2024 Conference Call for Tuesday, May 14, 2024 at 4:30 p.m. ET • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- VirTra to Introduce V-XR Training Solution at IAHSS Exhibition, Signaling Increased Commitment to Healthcare Security Training • GlobeNewswire Inc. • 04/29/2024 12:00:00 PM
- VirTra Awarded $5.9M Prototype Contract from U.S. Army IVAS Prime Contractor Microsoft • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- VirTra Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/02/2024 10:00:00 AM
- VirTra Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
- VirTra Sets Fourth Quarter and Full Year 2023 Conference Call for Monday, April 1, 2024 at 4:30 p.m. ET • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- VirTra to Participate in the 36th Annual ROTH Conference on March 17-19, 2024 • GlobeNewswire Inc. • 03/07/2024 01:00:00 PM
- VirTra CEO John Givens Appointed as Executive Committee Chair for National Center for Simulation • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- VirTra Debuts Advanced Training Content and True-Fire™ Recoil Kits at SHOT Show • GlobeNewswire Inc. • 01/18/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:05:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:05:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:05:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 09:17:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 09:15:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 09:42:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 09:40:26 PM
- VirTra Debuts New Integration of VBS4 at I/ITSEC 2023 to Support Military Clients • GlobeNewswire Inc. • 11/29/2023 10:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 09:19:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 09:18:37 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM